(D-Phe7)-Bradykinin is a modified bradykinin analog incorporating a D-phenylalanine residue at position 7 to enhance structural stability. The substitution alters receptor interaction dynamics, enabling detailed analysis of kinin-mediated signaling. Its activity provides insights into vascular tone regulation and inflammatory pathway modulation. Researchers employ it in studies of peptide-receptor selectivity and biochemical pathway mapping.
CAT No: B09038
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.